|
000
| 01154nam##2200277za#4500 |
|---|
| 001 | 9.615262 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210615101041 |
|---|
| 007 | ta |
|---|
| 008 | 150406|2000||||xxc||||| f|0| 0 eng|d |
|---|
| 020 | |a0-662-29195-6 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/67-19-2000E |
|---|
| 110 | 1 |aCanada. |bHealth Products and Food Branch. |
|---|
| 245 | 10|aQuality of biotechnological products : |banalysis of the expression construct in cells used for production of R-DNA derived protein products / |cIssued by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |c2000. |
|---|
| 300 | |aii, 5p. ; |c28 cm. |
|---|
| 490 | 1 |aGuidance for industry|vICH Topic Q5B |
|---|
| 500 | |aN.B.: Incorrect ISBN (0-662-84883-7) printed in this publication. |
|---|
| 563 | |aLoose-leaf |
|---|
| 590 | |a01-08|b2001-02-23 |
|---|
| 690 | 07|aBiotechnology|2gcpds |
|---|
| 690 | 07|aBiochemical products|2gcpds |
|---|
| 776 | 0#|tQuality of biotechnological products : |w(CaOODSP)9.573958 |
|---|
| 830 | #0|aGuidance for industry ;|vICH Topic Q5B|w(CaOODSP)9.514730 |
|---|